Drug Database
CM

CMV immunoglobulin (CytoGam)

✓ Approved

Sanofi S.A · 多克隆抗体 · 多克隆抗体

什么是 CMV immunoglobulin?

CMV immunoglobulin 是一种多克隆抗体,由Sanofi S.A研发。该药已获批,用于治疗相关适应症,给药途径:Injectable (Others)、Intravenous (IV)。

药物档案

商品名CytoGam
公司Sanofi S.A
药物类别多克隆抗体, 抗体
给药途径Injectable (Others), Intravenous (IV)
状态Approved

治疗适应症

CMV immunoglobulin 针对 1 个适应症,涉及 1 个治疗领域。

治疗领域疾病/病症分期
Surgical and medical proceduresAntiviral prophylaxis✓ Approved

相关研究文献

PubMedTurkish archives of pediatrics2026-11-17

Clinical Characteristics and Outcomes of Cytomegalovirus Infection in a Pediatric Intensive Care Unit.

Umur Ozge O, Bingol İbrahim İ, Coskun İpek İ, Topal Sevgi S et al.

The aim of this study was to describe the clinical characteristics, epidemiology, and outcomes of children with active cytomegalovirus (CMV) infection in a pediatric intensive care unit (PICU), and to identify risk factors associated with mortality. In this retrospective cohort study, medical records of patients admitted to a tertiary-level PICU between January 2015 and January 2023 were reviewed. Patients aged 1 month to 18 years with laboratory-confirmed CMV infection during PICU stay were included. Demographic, clinical, and outcome data were collected. Disease severity was assessed using pediatric risk of mortality (PRISM) and pediatric logistic organ dysfunction (PELOD) scores. Risk factors for mortality were analyzed using regression models, and the predictive value of CMV viral load was evaluated using receiver operating characteristic analysis. During the study period, a total of 3320 patients were admitted to the PICU, of whom 79 (2.38%; 95% CI, 1.9-2.9) had laboratory-confirmed CMV infection. Nearly half of the patients (n = 36, 45.6%) were immunocompromised. Overall mortality was 25.3% (n = 20). The main cause of death was septic shock (85%, n = 17). In most non-survivors (80%, n = 16), CMV polymerase chain reaction remained positive prior to death. A PELOD score ≥ 3 independently predicted mortality (crude RR 3.42; 95% CI, 2.98-7.78). Each 1-point increase in PRISM score was independently associated with mortality (crude RR 1.12; 95% CI, 1.05-1.20). Cytomegalovirus viral load demonstrated poor discriminative performance for mortality prediction ( Area Under the Curve-AUC 0.57; 95% CI, 0.47-0.63). The incidence of CMV infection in critically ill children was low but associated with high mortality. Organ dysfunction severity, particularly elevated PELOD scores, was a significant predictor of mortality. Pediatric risk of mortality score was statistically associated with mortality despite limited discriminative performance, whereas CMV viral load was not associated with mortality. These findings suggest that CMV infection in PICU patients likely reflects disease severity rather than being a direct determinant of outcome.

PMID 43041041
阅读全文 →
PubMedCureus2026-11-17

Left Eye Ocular Tuberculosis in an Immunocompromised Patient: A Diagnostic Dilemma.

Ibrahim Farah Ibtisam FI, Tuan Jaffar Tengku Norina TN, Tai Evelyn E

This case report discusses a 46-year-old male patient with a history of recurrent tuberculosis (TB) and human immunodeficiency virus (HIV), who presented with progressive left eye blurring of vision over two weeks, with eye redness and pain while hospitalized for disseminated cutaneous sporotrichosis. Initial investigations revealed a positive cytomegalovirus polymerase chain reaction test (CMV PCR) and tuberculin test, leading to a diagnosis of left eye CMV retinitis. Despite treatment with IV ganciclovir, the patient's ocular condition worsened, prompting a revised diagnosis of presumed ocular TB (OTB). The patient was started on intensive anti-TB therapy (ATT), and rapid regression of the choroidal lesion size and vitritis was observed two weeks after the commencement of ATT. The case highlights the diagnostic challenges and management complexities in patients with coexisting infections.

PMID 43042083
阅读全文 →
PubMedResearch (Washington, D.C.)2026-11-17

Magneto-Piezoelectric S-Scheme Nanozymes Reprogram Bacterial Energy Metabolism for Immune-Activated Pneumonia Therapy.

Zhang Shuai S, Qu Huanran H, Liu Ruocan R, Shao Shiyang S et al.

Chronic pulmonary infections caused by multidrug-resistant Pseudomonas aeruginosa (MDR-PA) biofilms remain difficult to eradicate because biofilm protection limits antibacterial efficacy and promotes immune evasion. Here, we develop an S-scheme heterojunction nanozyme, NEF/BMO@PVP (NBP), that integrates piezoelectric catalysis (PCT), nanozyme catalysis (NCT), and magnetothermal therapy (MHT) for non-antibiotic pneumonia treatment. Under ultrasound and alternating magnetic field stimulation, piezoelectric polarization, interfacial charge transfer, enzyme-mimetic catalysis, and magnetothermal acceleration cooperatively amplify reactive oxygen species (ROS) generation. NBP-induced oxidative stress was accompanied by disruption of bacterial metabolic homeostasis, including impaired coenzyme synthesis, respiratory electron transport, and adenosine triphosphate (ATP) production, together with alterations in GacS/GacA-associated regulatory factors, which may contribute to reduced biofilm formation and virulence-associated behaviors. In infected mice, NBP suppresses bacterial proliferation, enhances macrophage-mediated antigen presentation, alleviates T and B cell suppression, and reduces myeloid-derived suppressor cell infiltration, thereby restoring antibacterial immunity. NBP further activates memory T/B cell responses and increases pathogen-specific immunoglobulin G and immunoglobulin M production, providing protection against infection recurrence. This work establishes a magneto-piezoelectric S-scheme strategy that couples multichannel ROS amplification with bacterial energy-metabolism disruption and durable antibacterial immune activation.

PMID 43041565
阅读全文 →
PubMedJournal of hematology2026-11-17

Measles Pneumonia After Allogeneic Hematopoietic Stem Cell Transplantation.

Jimenez-Ochoa Marco Alejandro MA, Contreras-Serratos Maria Margarita MM, Urbina-Escalante Elizabeth E, Pardo-Escobedo Maria Gabriela MG et al.

Measles is a highly contagious viral infection that is rarely reported after allogeneic hematopoietic stem cell transplantation (HSCT), with only a limited number of cases described in the literature. We report the case of a 46-year-old woman who developed laboratory-confirmed measles complicated by atypical pneumonia 3 years after human leukocyte antigen (HLA)-identical sibling allogeneic HSCT for acute lymphoblastic leukemia. Her post-transplant course had been complicated by steroid-refractory chronic graft-versus-host disease (GVHD), successfully treated with ruxolitinib, which had been discontinued only a few months before presentation. She was admitted with fever, severe odynophagia, and diffuse oral mucosal erythema, leading to an initial diagnosis of chronic GVHD flare and treatment with corticosteroids and empirical antimicrobials. During hospitalization, she rapidly developed hypoxemic respiratory failure and a characteristic cephalocaudal maculopapular rash. Reverse transcription polymerase chain reaction (RT-PCR) of a throat swab confirmed measles virus infection. Corticosteroids were discontinued, and the patient received supportive care and intravenous immunoglobulin (IVIG), with complete clinical and radiologic recovery. Notably, despite adequate quantitative immune reconstitution, including preserved CD4+ and CD8+ T-cell counts and normal immunoglobulin levels, she remained susceptible to measles because she was not yet eligible for measles-mumps-rubella (MMR) vaccination according to current post-transplant recommendations. This case highlights the diagnostic challenge of distinguishing measles from chronic GVHD in transplant recipients, emphasizes that quantitative immune recovery does not necessarily reflect pathogen-specific immunity, and underscores the importance of maintaining a high index of suspicion and performing early molecular testing during community outbreaks.

PMID 43042413
阅读全文 →
PubMedJournal of investigative medicine : the official publication of the American Federation for Clinical Research2026-11-17

EXPRESS: A Meta-analysis Reporting the Most Common Infectious Complications in Relapsed/Refractory Multiple Myeloma Patients Treated with FDA Approved Bispecific Antibodies.

Shah Pranati Dharmesh PD, Yeremian Sofia S, Forte Emily E, Park Daniel D et al.

Bispecific antibodies (BsAbs) are used for relapsed or refractory multiple myeloma (RRMM), but infectious complications remain an important concern. We estimated the reported proportion of all-grade and grade ≥3 infections during teclistamab, talquetamab, and elranatamab treatment.A systematic literature review was conducted with Pubmed to extract data which, included the number of patients, grade ≥ 3 infectious adverse events, and non-grade ≥ 3 infectious adverse events. Analyses were conducted using R software and the meta package. A random effect model was utilized.Eight studies (6 RCTs, 2 retrospective studies) involving 946 patients (teclistamab: 394, talquetamab: 374, elranatamab: 178) were analyzed. Pooled proportion (PP) for teclistamab was 0.517 [95% CI, 0.183-0.837], and grade ≥ 3 was 0.233 [95% CI, 0.058-0.598]. The talquetamab group had a PP of 0.636 [95% CI, 0.305-0.874], and grade ≥ 3 were 0.201 [95% CI, 0.110-0.339], with COVID-19 & pneumonia most reported. For elranatamab, the PP was 0.714 [95% CI, 0.397-0.904], with grade ≥ 3 infections at 0.344 [95% CI, 0.015-0.948]. Common infections were adenovirus, CMV, COVID-19, and pneumocystis jirovecii. Table 2 shows consistently reported AEs amongst the three bispecific antibodies for comparability.Infections were frequently reported, but substantial heterogeneity limits the precision and generalizability of a single pooled estimate. Consistent outcome definitions and follow-up are needed.

PMID 43041151
阅读全文 →
PubMedGastroenterology research2026-11-17

Localized Gastric Amyloid Light Chain Amyloidosis With Atypical Depressed Morphology: Diagnostic Implications Based on Magnifying Endoscopy.

Miike Tadashi T, Kuroki Toshiki T, Ozono Yoshinori Y, Tsuzuki Ryo R et al.

Gastrointestinal involvement of amyloidosis is uncommon and cases limited to the stomach with a depressed lesion are limited. Here, we report the case of a 78-year-old woman who had a solitary 25-mm depressed lesion with irregular and indistinct boundaries in the lower gastric body with esophagogastroduodenoscopy (EGD). Chromoendoscopy (CE) revealed a coarse mucosal surface with a "moth-eaten" appearance, suggesting early gastric cancer. Magnifying narrow-band imaging (NBI) revealed partially preserved glandular structures and tortuous vessels without definite irregular microvascular patterns (IMVPs). Endoscopic ultrasonography (EUS) revealed a homogeneous hypoechoic thickening confined to the superficial layers. Histopathological examination revealed amyloid deposits in the submucosa. Congo red staining was positive and immunohistochemical analysis confirmed amyloid light-chain lambda-type (AL-λ) deposition. Comprehensive systemic evaluation showed no evidence of systemic involvement, establishing a diagnosis of localized gastric immunoglobulin light chain amyloidosis. Further accumulation of similar cases is required to clarify the characteristic endoscopic findings and their clinical significance.

PMID 43042215
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多CMV immunoglobulin